Compare $ACXP vs $APRE | Chartloom

Compare

$ACXP vs $APRE

Acurx Pharmaceuticals Inc · Aprea Therapeutics Inc

ACXP

Acurx Pharmaceuticals Inc

APRE

Aprea Therapeutics Inc

Compare $ACXP vs $APRE

Comparing Acurx Pharmaceuticals Inc and Aprea Therapeutics Inc

ACXPAcurx Pharmaceuticals Inc

APREAprea Therapeutics Inc

ACXPAcurx Pharmaceuticals Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-54.0%

52W performance

-84.3%

FCF yield

-113.2%

APREAprea Therapeutics Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-99.4%

YTD performance

-29.1%

52W performance

-57.8%

FCF yield

-162.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACXP

APRE

Detailed metrics comparison

ACXP

Acurx Pharmaceuticals Inc

APRE

Aprea Therapeutics Inc

Market Cap

ACXP$5M

APRE$7M

Enterprise Value

ACXP$-5M

APRE$-34M

Price

ACXP$1.27

APRE$0.60

P/E Ratio

ACXPN/A

APREN/A

P/S Ratio

ACXP0.00x

APRE1,438.94x

EV/Sales

ACXP0.00x

APRE-6,490.56x

EV/EBITDA

ACXP0.00x

APRE0.00x

P/B Ratio

ACXP0.87x

APRE0.22x

P/FCF Ratio

ACXPN/A

APREN/A

EV/FCF

ACXP0.84x

APRE2.77x

PEG Ratio

ACXPN/A

APREN/A

Forward P/E (NTM)

ACXPN/A

APREN/A

Forward P/S (NTM)

ACXPN/A

APREN/A

Revenue (TTM)

ACXP$0

APRE$5K

Revenue Growth (YoY)

ACXPN/A

APRE-99.4%

Forward Rev Growth

ACXP40.7%

APRE445.8%

Gross Margin (TTM)

ACXP0.0%

APRE0.0%

Operating Margin (TTM)

ACXP0.0%

APRE0.0%

EBITDA Margin (TTM)

ACXP0.0%

APRE-253869.2%

Net Margin (TTM)

ACXP0.0%

APRE-236676.9%

FCF Margin (TTM)

ACXPN/A

APRE-234296.2%

Net Income (TTM)

ACXP$-8M

APRE$-12M

FCF (TTM)

ACXP$-6M

APRE$-12M

EPS (TTM)

ACXP-$1.76

APRE-$0.23

ROE (TTM)

ACXP-12474.0%

APRE-4630.0%

ROA (TTM)

ACXP-8749.0%

APRE-4097.0%

ROIC (TTM)

ACXP-12474.0%

APRE-4630.0%

Cash

ACXP$11M

APRE$41M

Debt

ACXP$0

APRE$0

Net Cash/Debt

ACXP$11M

APRE$41M

Current Ratio (TTM)

ACXP3.88x

APRE13.55x

Quick Ratio (TTM)

ACXP3.80x

APRE13.33x

Debt/Equity (TTM)

ACXP0.00x

APRE0.00x

Debt/Assets (TTM)

ACXP0.0%

APRE0.0%

Interest Coverage (TTM)

ACXPN/A

APREN/A

Net Debt/EBITDA (TTM)

ACXP0.00x

APRE0.00x

Beta

ACXP-2.14

APRE-1.23

52W Performance

ACXP-84.3%

APRE-57.8%

YTD Performance

ACXP-54.0%

APRE-29.1%

% from 52W High

ACXP-84.4%

APRE-64.2%

% from 52W Low

ACXP3.3%

APRE10.3%

Asset Turnover (TTM)

ACXP0.00x

APRE0.02x

FCF Yield (TTM)

ACXP-113.2%

APRE-162.8%

Earnings Yield (TTM)

ACXP-137.5%

APRE-164.5%

Dividend Yield (TTM)

ACXPN/A

APREN/A

Rule of 40

ACXP0.0

APRE-234,395.5

EV/GP/RG

ACXPN/A

APREN/A

Ticker research

View ACXP research View APRE research

Metric	ACXP Acurx Pharmaceuticals Inc	APRE Aprea Therapeutics Inc
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-5M	$-34M
Price	$1.27	$0.60
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1,438.94x
EV/Sales	0.00x	-6,490.56x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	0.22x
P/FCF Ratio	N/A	N/A
EV/FCF	0.84x	2.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$5K
Revenue Growth (YoY)	N/A	-99.4%
Forward Rev Growth	40.7%	445.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-253869.2%
Net Margin (TTM)	0.0%	-236676.9%
FCF Margin (TTM)	N/A	-234296.2%
Net Income (TTM)	$-8M	$-12M
FCF (TTM)	$-6M	$-12M
EPS (TTM)	-$1.76	-$0.23
ROE (TTM)	-12474.0%	-4630.0%
ROA (TTM)	-8749.0%	-4097.0%
ROIC (TTM)	-12474.0%	-4630.0%
Financial Health
Cash	$11M	$41M
Debt	$0	$0
Net Cash/Debt	$11M	$41M
Current Ratio (TTM)	3.88x	13.55x
Quick Ratio (TTM)	3.80x	13.33x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.14	-1.23
52W Performance	-84.3%	-57.8%
YTD Performance	-54.0%	-29.1%
% from 52W High	-84.4%	-64.2%
% from 52W Low	3.3%	10.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-113.2%	-162.8%
Earnings Yield (TTM)	-137.5%	-164.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-234,395.5
EV/GP/RG	N/A	N/A
Ticker research	View ACXP research	View APRE research

Valuation

P/S Ratio

ACXP

0.00x

APRE

1,438.94x

EV/FCF

ACXP

0.84x

APRE

2.77x

Growth & revenue

Revenue Growth TTM

APRE

-99.4%

Forward Revenue Growth

APRE

445.8%

ACXP

40.7%

Profitability & performance

Gross Margin

ACXP

0.0%

APRE

0.0%

ROE

APRE

-4630.0%

ACXP

-12474.0%

FCF Yield %

ACXP

-113.2%

APRE

-162.8%

52-Week Performance

APRE

-57.8%

ACXP

-84.3%

Detailed metrics comparison

ACXP

Acurx Pharmaceuticals Inc

APRE

Aprea Therapeutics Inc

Market Cap

ACXP$5M

APRE$7M

Enterprise Value

ACXP$-5M

APRE$-34M

Price

ACXP$1.27

APRE$0.60

P/E Ratio

ACXPN/A

APREN/A

P/S Ratio

ACXP0.00x

APRE1,438.94x

EV/Sales

ACXP0.00x

APRE-6,490.56x

EV/EBITDA

ACXP0.00x

APRE0.00x

P/B Ratio

ACXP0.87x

APRE0.22x

P/FCF Ratio

ACXPN/A

APREN/A

EV/FCF

ACXP0.84x

APRE2.77x

PEG Ratio

ACXPN/A

APREN/A

Forward P/E (NTM)

ACXPN/A

APREN/A

Forward P/S (NTM)

ACXPN/A

APREN/A

Revenue (TTM)

ACXP$0

APRE$5K

Revenue Growth (YoY)

ACXPN/A

APRE-99.4%

Forward Rev Growth

ACXP40.7%

APRE445.8%

Gross Margin (TTM)

ACXP0.0%

APRE0.0%

Operating Margin (TTM)

ACXP0.0%

APRE0.0%

EBITDA Margin (TTM)

ACXP0.0%

APRE-253869.2%

Net Margin (TTM)

ACXP0.0%

APRE-236676.9%

FCF Margin (TTM)

ACXPN/A

APRE-234296.2%

Net Income (TTM)

ACXP$-8M

APRE$-12M

FCF (TTM)

ACXP$-6M

APRE$-12M

EPS (TTM)

ACXP-$1.76

APRE-$0.23

ROE (TTM)

ACXP-12474.0%

APRE-4630.0%

ROA (TTM)

ACXP-8749.0%

APRE-4097.0%

ROIC (TTM)

ACXP-12474.0%

APRE-4630.0%

Cash

ACXP$11M

APRE$41M

Debt

ACXP$0

APRE$0

Net Cash/Debt

ACXP$11M

APRE$41M

Current Ratio (TTM)

ACXP3.88x

APRE13.55x

Quick Ratio (TTM)

ACXP3.80x

APRE13.33x

Debt/Equity (TTM)

ACXP0.00x

APRE0.00x

Debt/Assets (TTM)

ACXP0.0%

APRE0.0%

Interest Coverage (TTM)

ACXPN/A

APREN/A

Net Debt/EBITDA (TTM)

ACXP0.00x

APRE0.00x

Beta

ACXP-2.14

APRE-1.23

52W Performance

ACXP-84.3%

APRE-57.8%

YTD Performance

ACXP-54.0%

APRE-29.1%

% from 52W High

ACXP-84.4%

APRE-64.2%

% from 52W Low

ACXP3.3%

APRE10.3%

Asset Turnover (TTM)

ACXP0.00x

APRE0.02x

FCF Yield (TTM)

ACXP-113.2%

APRE-162.8%

Earnings Yield (TTM)

ACXP-137.5%

APRE-164.5%

Dividend Yield (TTM)

ACXPN/A

APREN/A

Rule of 40

ACXP0.0

APRE-234,395.5

EV/GP/RG

ACXPN/A

APREN/A

Ticker research

View ACXP research View APRE research

Metric	ACXP Acurx Pharmaceuticals Inc	APRE Aprea Therapeutics Inc
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-5M	$-34M
Price	$1.27	$0.60
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1,438.94x
EV/Sales	0.00x	-6,490.56x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.87x	0.22x
P/FCF Ratio	N/A	N/A
EV/FCF	0.84x	2.77x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$5K
Revenue Growth (YoY)	N/A	-99.4%
Forward Rev Growth	40.7%	445.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-253869.2%
Net Margin (TTM)	0.0%	-236676.9%
FCF Margin (TTM)	N/A	-234296.2%
Net Income (TTM)	$-8M	$-12M
FCF (TTM)	$-6M	$-12M
EPS (TTM)	-$1.76	-$0.23
ROE (TTM)	-12474.0%	-4630.0%
ROA (TTM)	-8749.0%	-4097.0%
ROIC (TTM)	-12474.0%	-4630.0%
Financial Health
Cash	$11M	$41M
Debt	$0	$0
Net Cash/Debt	$11M	$41M
Current Ratio (TTM)	3.88x	13.55x
Quick Ratio (TTM)	3.80x	13.33x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.14	-1.23
52W Performance	-84.3%	-57.8%
YTD Performance	-54.0%	-29.1%
% from 52W High	-84.4%	-64.2%
% from 52W Low	3.3%	10.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-113.2%	-162.8%
Earnings Yield (TTM)	-137.5%	-164.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-234,395.5
EV/GP/RG	N/A	N/A
Ticker research	View ACXP research	View APRE research